Precigen, Inc. (PGEN)
3.705
-0.18
(-4.76%)
USD |
NASDAQ |
Mar 27, 13:44
Precigen EPS Diluted (Quarterly) : -0.0664 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1022 |
| Amneal Pharmaceuticals, Inc. | 0.1069 |
| Corcept Therapeutics, Inc. | 0.1994 |
| CorMedix, Inc. | 0.1493 |
| Viridian Therapeutics, Inc. | -1.080 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.50M |
| Revenue (Quarterly) | 4.565M |
| Total Expenses (Quarterly) | 28.07M |
| Enterprise Value | 1.377B |
| Gross Profit Margin (Quarterly) | 58.07% |
| Profit Margin (Quarterly) | -514.9% |
| Earnings Yield | -37.78% |
| Normalized Earnings Yield | -28.87 |